Here are three updates from gastroenterology companies and practices from the past week:
The FDA accepted Pfizer's supplemental New Drug Application for its combination therapy for advanced BRAF-mutant metastatic colorectal cancer and granted it priority review designation.
Check-Cap reported final results from its U.S. pilot study of its C-Scan System, a preparation-free colorectal cancer detection system.
Hattiesburg, Miss.-based Forrest General Hospital added Porter Glover, MD, Telciane Vesa, MD, and Andrew Weeks, MD, to its gastroenterology care team.